Format

Send to

Choose Destination
Curr Oncol. 2018 Apr;25(2):139-148. doi: 10.3747/co.25.3790. Epub 2018 Apr 30.

Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.

Author information

1
Salish Cancer Center, Fife, WA, U.S.A.
2
Naturopathic Specialists, Scottsdale, AZ, U.S.A.
3
Department of Research and Clinical Epidemiology, Ottawa Integrative Cancer Centre, Ottawa, ON.
4
Department of Medical Oncology, Cancer Treatment Centers of America, Philadelphia, PA, U.S.A.

Abstract

This article reviews intravenous vitamin C (IV C) in cancer care and offers a rational approach to enable medical oncologists and integrative practitioners to safely provide IV C combined with oral vitamin C to patients. The use of IV C is a safe supportive intervention to decrease inflammation in the patient and to improve symptoms related to antioxidant deficiency, disease processes, and side effects of standard cancer treatments. A proposed rationale, together with relevant clinical safety considerations for the application of IV C in oncologic supportive care, is provided.

KEYWORDS:

Vitamin C deficiency; ascorbate; intravenous vitamin C; quality of life; supportive care

Supplemental Content

Full text links

Icon for Multimed Inc. Icon for PubMed Central
Loading ...
Support Center